Whittemore Tingley

CIK: 0001868494

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)16 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)4 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TNYA

Tenaya Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (24 total)

TNYA
Tenaya Therapeutics, Inc.
Sep 10, 2026
Award(A)
Direct
49K shares-
TNYA
Tenaya Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Direct
1.6K shares at avg. $0.71$1K
TNYA
Tenaya Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Direct
1.6K shares at avg. $0.71$1K
TNYA
Tenaya Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Direct
1.9K shares at avg. $0.71$1K
TNYA
Tenaya Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Direct
2.3K shares at avg. $0.71$2K
TNYA
Tenaya Therapeutics, Inc.
May 18, 2026
Sale(S)
Direct
3.1K shares at avg. $0.79$2K
TNYA
Tenaya Therapeutics, Inc.
Feb 17, 2026
Sale(S)
Direct
1.6K shares at avg. $0.64$1K
TNYA
Tenaya Therapeutics, Inc.
Feb 17, 2026
Sale(S)
Direct
1.9K shares at avg. $0.64$1K
TNYA
Tenaya Therapeutics, Inc.
Feb 17, 2026
Sale(S)
Direct
1.6K shares at avg. $0.64$1K
TNYA
Tenaya Therapeutics, Inc.
Feb 3, 2026
Award(A)
Direct
48.8K shares-
TNYA
Tenaya Therapeutics, Inc.
Nov 17, 2025
Sale(S)
Direct
2.9K shares at avg. $1.33$4K
TNYA
Tenaya Therapeutics, Inc.
Aug 18, 2025
Sale(S)
Direct
1.6K shares at avg. $1.25$2K
TNYA
Tenaya Therapeutics, Inc.
Aug 18, 2025
Sale(S)
Direct
1.6K shares at avg. $1.25$2K
TNYA
Tenaya Therapeutics, Inc.
Aug 18, 2025
Sale(S)
Direct
1.8K shares at avg. $1.25$2K
TNYA
Tenaya Therapeutics, Inc.
May 16, 2025
Sale(S)
Direct
2.9K shares at avg. $0.44$1K
TNYA
Tenaya Therapeutics, Inc.
Mar 10, 2025
Sale(S)
Direct
1.6K shares at avg. $0.54$860.363
TNYA
Tenaya Therapeutics, Inc.
Mar 10, 2025
Sale(S)
Direct
4.1K shares at avg. $0.54$2K
TNYA
Tenaya Therapeutics, Inc.
Mar 10, 2025
Sale(S)
Direct
1.7K shares at avg. $0.54$929.817
TNYA
Tenaya Therapeutics, Inc.
Jan 24, 2025
Award(A)
Direct
31.7K shares-
TNYA
Tenaya Therapeutics, Inc.
Jan 24, 2025
Award(A)
Direct
40K shares-
TNYA
Tenaya Therapeutics, Inc.
Jan 24, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
70K shares-
TNYA
Tenaya Therapeutics, Inc.
Jan 24, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
141K shares-
TNYA
Tenaya Therapeutics, Inc.
Jan 24, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
205K shares-
TNYA
Tenaya Therapeutics, Inc.
Jan 24, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
215K shares-

		Type	Shares	Price		Ownership
Sep 10, 2026	TNYA Tenaya Therapeutics, Inc.	Award(A)	49,000	-	$0	Direct
Aug 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,637	$0.71	$1,162	Direct
Aug 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,637	$0.71	$1,162	Direct
Aug 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,871	$0.71	$1,328	Direct
Aug 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	2,279	$0.71	$1,618	Direct
May 18, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	3,121	$0.79	$2,477	Direct
Feb 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,642	$0.64	$1,056	Direct
Feb 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,876	$0.64	$1,206	Direct
Feb 17, 2026	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,642	$0.64	$1,056	Direct
Feb 3, 2026	TNYA Tenaya Therapeutics, Inc.	Award(A)	48,750	-	$0	Direct
Nov 17, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	2,877	$1.33	$3,826	Direct
Aug 18, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,608	$1.25	$2,015	Direct
Aug 18, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,608	$1.25	$2,015	Direct
Aug 18, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,837	$1.25	$2,302	Direct
May 16, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	2,937	$0.44	$1,300	Direct
Mar 10, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,598	$0.54	$860	Direct
Mar 10, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	4,073	$0.54	$2,193	Direct
Mar 10, 2025	TNYA Tenaya Therapeutics, Inc.	Sale(S)	1,727	$0.54	$930	Direct
Jan 24, 2025	TNYA Tenaya Therapeutics, Inc.	Award(A)	31,676	-	$0	Direct
Jan 24, 2025	TNYA Tenaya Therapeutics, Inc.	Award(A)	40,000	-	$0	Direct
Jan 24, 2025	TNYA Tenaya Therapeutics, Inc.	Disposition(D) Stock Option (Right to Buy)	69,982	-	-	Direct
Jan 24, 2025	TNYA Tenaya Therapeutics, Inc.	Disposition(D) Stock Option (Right to Buy)	141,000	-	-	Direct
Jan 24, 2025	TNYA Tenaya Therapeutics, Inc.	Disposition(D) Stock Option (Right to Buy)	205,000	-	-	Direct
Jan 24, 2025	TNYA Tenaya Therapeutics, Inc.	Disposition(D) Stock Option (Right to Buy)	215,000	-	-	Direct

1-24 of 24 transactions

About Tingley Whittemore

Tingley Whittemore (SEC CIK 0001868494) files insider reports with the SEC as Chief Medical Officer of Tenaya Therapeutics, Inc. (TNYA).

Signal8 holds 10 ownership filings by Tingley Whittemore, all Form 4s, filed between Jan 28, 2025 and Sep 11, 2026. Those filings report 24 transactions, from Jan 24, 2025 to Sep 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Tingley Whittemore's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Tingley Whittemore

Sep 10, 2026: Grant or award of TNYA shares (Form 4, code A).
Aug 17, 2026: Open-market sales of TNYA shares (4 lines, Form 4, code S).
May 18, 2026: Open-market sale of TNYA shares (Form 4, code S).
Feb 17, 2026: Open-market sales of TNYA shares (3 lines, Form 4, code S).
Feb 3, 2026: Grant or award of TNYA shares (Form 4, code A).

Other insiders filing for Tenaya Therapeutics, Inc. (TNYA)

Ali Faraz, Chief Executive Officer
Hyllengren Eric J, Chief Financial Officer
Williams R Sanders, Director
Walsh Jeffrey T., Director
Stehman-Breen Catherine, Director
Srivastava Deepak, Director

How to read Form 4 transaction codes